Owners, management and financials
CVR: 41277688
DKK -30,768
Gross profit
Net result: DKK -144,214
Ritika Singh Petersen (5-9,99%), Sriram Thoppe Rajendran (5-9,99%)
5 more
CVR · view owners
Michael Henrik Stadi
Board: Martin Kiener (chair) and 2 members
CVR · view management
Active
Founded 3 April 2020
CVR · view overview
0 employees
Annual report 2021 · average
Owner registered: Ritika Singh Petersen
CVR · 30/09/2021
View the full event history
MLMC Therapeutics ApS is a Danish company of the type Anpartsselskab based in Kastrup, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Michael Henrik Stadi. The board consists of Martin Kiener (chair), Hanne Damgaard Jensen and Peter Gudmund Nielsen. The company's owners include Ritika Singh Petersen, Sriram Thoppe Rajendran and FOMT HOLDING ApS. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -30,768 and a net result of DKK -144,214 compared with DKK -134,525 the year before. Equity in the 2025 report amounted to DKK -483,287.
Selskabets formål er forskning i og udvikling af teknologi til produktion af oral medicin, samt aktiviteter, som efter ledelsens skøn naturligt står i forbindelse hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -31K | -144K | 89K | -483K | - | |
| 202401/01/2024 – 31/12/2024 | -27K | -135K | 159K | -339K | - | |
| 202301/01/2023 – 31/12/2023 | -26K | -123K | 217K | -205K | - | |
| 202201/01/2022 – 31/12/2022 | -30K | -90K | 220K | -82K | - | |
| 202101/01/2021 – 31/12/2021 | -20K | -54K | 176K | 8K | 0 |
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of MLMC Therapeutics ApS is 41277688.
The owners of MLMC Therapeutics ApS include Ritika Singh Petersen, Sriram Thoppe Rajendran and FOMT HOLDING ApS.
The management of MLMC Therapeutics ApS consists of Michael Henrik Stadi.
The board of MLMC Therapeutics ApS consists of Martin Kiener, Hanne Damgaard Jensen and Peter Gudmund Nielsen, with Martin Kiener as chair.
In 2025, MLMC Therapeutics ApS reported a gross profit of DKK -30,768.
MLMC Therapeutics ApS had an average of 0 employees in the 2021 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
MLMC Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -30,768, and the net result was DKK -144,214.
MLMC Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -26,638, and the net result was DKK -134,525.
MLMC Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -25,639, and the net result was DKK -122,678.
MLMC Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -29,822, and the net result was DKK -90,240.
As of May 1, 2023, A/S PSE 17 NR. 1056 has stepped down as auditor of MLMC Therapeutics ApS.
As of June 15, 2022, A/S PSE 17 NR. 1056 has been appointed auditor of MLMC Therapeutics ApS.
As of June 15, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MLMC Therapeutics ApS.
MLMC Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK -19,909, and the net result was DKK -53,670.
As of September 30, 2021, Ritika Singh Petersen is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
As of September 30, 2021, Sriram Thoppe Rajendran is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
MLMC Therapeutics ApS has published its interim report for the period April 3, 2020 to December 31, 2020.
As of April 27, 2020, FOMT HOLDING ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 10%.
As of April 27, 2020, CORIDATS CAPITAL ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 10%.
As of April 27, 2020, Scantox Ballerup ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
As of April 27, 2020, FOM TECHNOLOGIES A/S is registered as an owner of MLMC Therapeutics ApS with an ownership share of 50%.
As of April 27, 2020, HDJ & LEJ Invest ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
As of April 3, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MLMC Therapeutics ApS.
As of April 3, 2020, Hanne Damgaard Jensen has joined the board of directors of MLMC Therapeutics ApS.
As of April 3, 2020, Peter Gudmund Nielsen has joined the board of directors of MLMC Therapeutics ApS.
As of April 3, 2020, Martin Kiener has joined the board of directors of MLMC Therapeutics ApS.
As of April 3, 2020, Michael Henrik Stadi is registered as adm. dir. of MLMC Therapeutics ApS.
MLMC Therapeutics ApS was founded on April 3, 2020.
Companies in the same industry and area
CVR 34715726
CVR 37723312
CVR 16313440
CVR 38789902
CVR 46527232
